[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury
Authors:
- 1 February 1994
- journal article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 14 (1) , 99-104
Abstract
1. Intracerebral injection of the oxidative metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 1-methyl-4-phenylpyridine (MPP+), into the substantia nigra of adult rats resulted in a lesion at the injection site. 2. Using autoradiography, we localized specific [125]CGP 42112 binding that was not recognized by angiostensin II or angiotensin II AT1 or AT2 receptorselective ligands. 3. Our results suggest that [125I]CGP 42112 may be binding to activated microglia that appear at the lesion site.Keywords
This publication has 23 references indexed in Scilit:
- Angiotensin II receptors and angiotensin II receptor antagonists.Pharmacological Reviews, 1993
- Angiotensin II Receptor Subtypes: Characterization, Signalling Mechanisms, and Possible Physiological ImplicationsFrontiers in Neuroendocrinology, 1993
- Reactive glia as rivals in regulating neuronal survivalGlia, 1993
- Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta.Journal of Clinical Investigation, 1992
- Radioiodinated CGP 42111A: A novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptorsBiochemical and Biophysical Research Communications, 1991
- Macrophages and the Nervous System1991
- The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degenerationNeuroscience, 1991
- Peptides released by ameboid microglia regulate astroglial proliferation.Journal of Cell Biology, 1985
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979